What is the recommended management of an acute asthma exacerbation in an older adult?

Management of Acute Asthma Exacerbation in Older Adults

Immediately administer high-dose inhaled beta-agonists (salbutamol 5 mg or terbutaline 10 mg nebulized with oxygen) and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) at the same time, without delay. 1

Initial Assessment and Recognition

Older adults with acute asthma require objective measurements because physical examination alone significantly underestimates severity in this population. Elderly asthmatics demonstrate less marked tachycardia and pulsus paradoxus compared to younger patients despite similar degrees of airflow obstruction and blood gas abnormalities 2. This blunted cardiovascular response to hypoxia and bronchoconstriction means you cannot rely on heart rate or blood pressure to gauge severity 3.

Severity Classification

Severe asthma features (begin treatment immediately):

• Peak expiratory flow (PEF) <50% predicted or personal best
• Respiratory rate >25 breaths/min
• Heart rate >110 beats/min
• Unable to complete sentences in one breath 1

Life-threatening features (require intensive monitoring):

• PEF <33% predicted or personal best
• Silent chest, cyanosis, or feeble respiratory effort
• Bradycardia or hypotension
• Exhaustion, confusion, or coma
• Normal or elevated PaCO₂ (5-6 kPa or higher) in a breathless patient
• Severe hypoxia: PaO₂ <8 kPa despite oxygen
• Low pH 1

Immediate Treatment Algorithm

Step 1: Bronchodilation + Steroids (Start Simultaneously)

High-dose inhaled beta-agonists:

• Nebulized salbutamol 5 mg or terbutaline 10 mg with oxygen
• Alternative: 20-40 puffs (10-20 actuations of 2 puffs each) via metered-dose inhaler with large spacer device 1

High-dose systemic corticosteroids:

• Prednisolone 30-60 mg orally OR
• Hydrocortisone 200 mg IV OR
• Both together 1

The IV route is preferable in severe exacerbations, though oral and IV formulations show similar clinical effects 4. Corticosteroids take 6-12 hours to show effect, making early administration critical 4.

Step 2: Add Anticholinergics for Life-Threatening Features

If life-threatening features present:

• Add ipratropium 0.5 mg nebulized to the beta-agonist 1
• This combination produces modest but clinically meaningful improvement in lung function 4
• Continue every 20 minutes for 3 doses, then as needed 5

Step 3: IV Therapy for Refractory Cases

If life-threatening features persist:

• IV aminophylline 250 mg over 20 minutes OR
• IV salbutamol or terbutaline 250 µg over 10 minutes 1

Critical caveat: Do NOT give bolus aminophylline to patients already taking oral theophyllines 1

Alternative consideration: IV magnesium sulfate 2 g over 20 minutes improves pulmonary function and reduces hospital admissions in severe exacerbations 4

Monitoring and Reassessment

Measure PEF 15-30 minutes after starting treatment and reassess response 1:

• If improving: Continue nebulized beta-agonist every 4 hours
• If NOT improving after 15-30 minutes: Give nebulized beta-agonists more frequently (up to every 15 minutes) 1
• If still unsatisfactory: Consider aminophylline or parenteral beta-agonist 1

Continue oxygen therapy throughout and maintain high-dose steroids (prednisolone 30-60 mg daily or hydrocortisone 200 mg every 6 hours) 1.

Special Considerations for Older Adults

Diagnostic Workup in Hospital

In older patients specifically, obtain:

• Chest radiography (exclude pneumothorax, consolidation, pulmonary edema)
• Plasma electrolytes and urea
• Blood count
• Electrocardiography (specifically mentioned for older patients) 1

Safety of Epinephrine

Despite historical concerns, subcutaneous epinephrine (0.3-0.5 mg every 20 minutes for 3 doses) is safe in older adults without recent MI or angina, with no increased ventricular arrhythmias and actual decreases in blood pressure and heart rate with treatment 6. However, inhaled beta-agonists remain first-line as systemic therapy shows no proven advantage 5.

Response Patterns

Elderly asthmatics improve at similar rates to younger patients, but those on maintenance oral corticosteroids are less likely to reach predicted PEF than their peers or younger patients 2. This means you should set realistic discharge goals based on personal best rather than predicted values.

Hospital Admission Criteria

Immediate hospital referral for:

• Any life-threatening features
• Severe attack features persisting after initial treatment
• PEF <33% predicted or best 15-30 minutes after nebulization 1

Lower threshold for admission in older adults when:

• Seen in afternoon/evening rather than morning
• Recent nocturnal symptoms or symptom worsening
• Previous severe attacks, especially rapid onset
• Concern about patient's ability to assess severity
• Social circumstances or caregiver concerns 1

Intensive Care Indications

Transfer to ICU for:

• Deteriorating PEF, worsening/persisting hypoxia (PaO₂ <8 kPa) despite 60% oxygen, or hypercapnia (PaCO₂ >6 kPa)
• Exhaustion, feeble respiration, confusion, or drowsiness
• Coma or respiratory arrest 1

Intubation and mechanical ventilation required for:

• Worsening hypoxia or hypercapnia
• Drowsiness or unconsciousness
• Respiratory arrest 1

What NOT to Do

• No antibiotics unless bacterial infection confirmed 1
• No sedation (absolutely contraindicated) 1
• No chest physiotherapy (unnecessary) 1

Discharge Planning

Do not discharge until:

• PEF >75% predicted or personal best
• Diurnal PEF variability <25%
• No nocturnal symptoms
• Stable on discharge medications for 24 hours 1

Discharge with:

• Prednisolone tablets 30 mg daily or more for 1-3 weeks
• Inhaled corticosteroids in addition to bronchodilators
• Peak flow meter
• GP follow-up within 1 week
• Respiratory clinic follow-up within 4 weeks 1